Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;

Executive summary. Diagnosis, treatment and prophylaxis of in¿uenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS) Francisco López-Medrano; Santiago Alfayate; Jordi Carratalà; Judith Chamorro-Camazón; Elisa Cordero; Marta Cruz-Cañete; María Fernández-Prada; Manuel García-Cenoz; María Ángeles Marcos; Santiago Melón; Nemesio Moreno-Millán; María Ángeles Onieva-García; Raúl Ortiz de Lejarazu; Jaime Jesús Pérez-Martín; Juan Rodríguez-García; Germán Schwarz-Chavarri; Alfredo Tagarro-García; Diego van Esso-Arbolave; Diego Viasus; Tomàs Pumarola;

Main changes in the ¿COVID-19 in paediatrics¿ clinical practice guideline Javier González de Dios; Victoria Martínez Rubio; Álvaro Giménez Díaz de Atauri; Carlos Ochoa Sangrador; Enrique Rodríguez-Salinas Pérez; Sergio Flores Villar; Jaime Javier Cuervo Valdés;